Clinical Trials Browser

Phase 2 × NIH × sarilumab × Clear all

NCT03770273 2024-12-17

Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis

Phase 2 Completed

21 enrolled 13 charts

Mastocytosis, Systemic